Benjamin Paluch

Stock Analyst at Roth MKM

(1.31)

# 3,683

Out of 5,245 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$64.13	+1.36%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$4.91	+246.23%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.92	+242.47%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $64.13

Upside: +1.36%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $4.91

Upside: +246.23%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.92

Upside: +242.47%